IPOPLUS

₹1,269.8

▲ +12.6 +1.00%

17 Jun 2026

NSE Listed

Senores Pharmaceuticals (SENORES)

Volume: 2,13,031Avg Vol 1W: 2,59,245.4Avg Vol 1M: 2,95,790.3552W Range:₹513₹1,311
NSE BSE
₹1,269.8▲ 1.00%
Key Ratios
Updated 4h ago
Market Cap₹5,947 Cr
Current Price₹1,269.8
Previous Close₹1,257.2
High / Low (52w)₹1,311 / ₹513
Volume2,13,031
Avg Vol (1W)2,59,245.4
Avg Vol (1M)2,95,790.35
Stock P/E120.86
Book Value₹202.74
Dividend Yield0%
ROE12.4%
ROA7.6%
Revenue (TTM)₹418 Cr
Revenue Growth85.7%
Profit Margin18.3%
Total Debt₹162 Cr
Shares Outstanding5 Cr
Face Value₹10
EPS (TTM)₹7.96
P/B6.37
Debt / Equity0.37
50 DMA₹816.36
200 DMA₹769.65
Day change+1.00%
Price Chart
₹1,269.8▲ 137.35% · 1Y
₹1270₹51877.5L
2025-06-17
2026-05-11

20-day avg volume: 3.0L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 45% YoY.
  • Stock trades at a high P/E of 121.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹80 Cr₹101 Cr₹103 Cr₹114 Cr₹138 Cr₹162 Cr₹171 Cr₹175 Cr
EBITDA₹18 Cr₹21 Cr₹27 Cr₹26 Cr₹32 Cr₹47 Cr₹50 Cr₹56 Cr
Net Profit₹11 Cr₹13 Cr₹17 Cr₹18 Cr₹20 Cr₹32 Cr₹32 Cr₹32 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹8 Cr₹15 Cr₹39 Cr₹217 Cr₹418 Cr
EBITDA₹1 Cr₹2 Cr₹15 Cr₹34 Cr₹92 Cr
Net Profit₹1 Cr₹1 Cr₹8 Cr₹31 Cr₹59 Cr
EPS—————
Balance Sheet
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹15 Cr₹59 Cr₹131 Cr₹622 Cr₹1,227 Cr
Total Liabilities₹5 Cr₹23 Cr₹86 Cr₹390 Cr₹415 Cr
Equity₹9 Cr₹37 Cr₹46 Cr₹232 Cr₹812 Cr
Total Debt₹3 Cr₹2 Cr₹6 Cr₹134 Cr₹162 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-3 Cr₹-10 Cr₹0 Cr₹-23 Cr₹-37 Cr
Investing₹-4 Cr₹-24 Cr₹-48 Cr₹-54 Cr₹-429 Cr
Financing₹9 Cr₹36 Cr₹46 Cr₹87 Cr₹573 Cr
Free Cash Flow₹-6 Cr₹-10 Cr₹0 Cr₹-23 Cr₹-37 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search